Sign Up
Stories
Assertio Holdings in Crisis: Securities Fraud Allegations
Share
ASRT Securities Fraud Allegations
Activist Investor Targets Alight's Impro...
B. Riley Faces Securities Fraud
ASRT Investor Claims Amid Fraud Allegati...
ASRT Investors Alerted Amid Alleged Misr...
ASRT Investors Alerted Amid Legal Challe...
Overview
API
Assertio Holdings, Inc. faces Securities Fraud Class Action Suit over alleged misrepresentation. Investors affected between Mar. 9, 2023, and Nov. 8, 2023, given Mar. 5, 2024, deadline for claims. CEO termination and stock price target reduction add to company woes.
Ask a question
How can investors protect themselves from similar situations in the future?
How might Assertio Holdings' reputation and stock value be affected in the long term?
What regulatory changes could arise in the pharmaceutical industry following this case?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Nov 2023
Dec 2023
Jan 2024
Coverage